Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Medexus Pharmaceuticals Inc (MDP.VN)

Medexus Pharmaceuticals Inc (MDP.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Complete Response Letter Received from FDA for Treosulfan Globe NewsWire - Tue Aug 3, 2021

TORONTO and CHICAGO and WEDEL, Germany, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“ Medexus ” or the “ Company ”) (TSX: MDP) (OTCQX: MEDXF) and medac GmbH (“medac”)...

MDP.VN : 7.750 (-4.91%)
MDP.TO : 1.86 (+6.90%)
MEDXF : 1.3500 (+3.85%)
Medexus Appoints New Chief Financial Officer Globe NewsWire - Mon Jul 19, 2021

TORONTO and CHICAGO, July 19, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) is pleased to announce the appointment of Marcel Konrad...

MDP.VN : 7.750 (-4.91%)
MDP.TO : 1.86 (+6.90%)
MEDXF : 1.3500 (+3.85%)
CDNA : 7.56 (-5.26%)
Medexus Pharmaceuticals and medac GmbH enter into Licensing Agreement for First-in-Class Conditioning Agent, Treosulfan, in Canada Globe NewsWire - Mon Jul 12, 2021

TORONTO and CHICAGO and WEDEL, Germany, July 12, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “ Medexus ”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has...

MDP.VN : 7.750 (-4.91%)
MDP.TO : 1.86 (+6.90%)
MEDXF : 1.3500 (+3.85%)
Medexus Receives Notice of Compliance to Commercialize Treosulfan in Canada Globe NewsWire - Mon Jun 28, 2021

TORONTO and CHICAGO, June 28, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “ Medexus ”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has received a Notice of...

MDP.VN : 7.750 (-4.91%)
MDP.TO : 1.86 (+6.90%)
MEDXF : 1.3500 (+3.85%)
Medexus Revenue Increases 43.5% to a Record US$79.7 Million for Fiscal 2021 Globe NewsWire - Wed Jun 16, 2021

Transformative licensing agreement for treosulfan in the U.S. completed February 2, 2021

MDP.VN : 7.750 (-4.91%)
MDP.TO : 1.86 (+6.90%)
MEDXF : 1.3500 (+3.85%)
Medexus Announces Graduation to the Toronto Stock Exchange Globe NewsWire - Tue Jun 15, 2021

TORONTO and CHICAGO and MONTREAL, June 15, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSXV:MDP) (OTCQX: MEDXF) announced today that it has received final...

MDP.VN : 7.750 (-4.91%)
MEDXF : 1.3500 (+3.85%)
Medexus to Present at Raymond James Human Health Innovation Conference Globe NewsWire - Mon Jun 14, 2021

TORONTO, CHICAGO and MONTREAL, June 14, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or  “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731)   announced today...

MDP.VN : 7.750 (-4.91%)
MEDXF : 1.3500 (+3.85%)
Medexus Schedules Fiscal Year 2021 Conference Call Globe NewsWire - Fri Jun 11, 2021

TORONTO and CHICAGO and MONTREAL, June 11, 2021 (GLOBE NEWSWIRE) -- , June 11, 2021 - Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731)...

MDP.VN : 7.750 (-4.91%)
MEDXF : 1.3500 (+3.85%)
Medexus Strengthens Medical Affairs Team in Preparation for Planned Treosulfan Launch Globe NewsWire - Thu Jun 10, 2021

TORONTO, CHICAGO and MONTREAL, June 10, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or  “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced that...

MDP.VN : 7.750 (-4.91%)
MEDXF : 1.3500 (+3.85%)
Medexus Announces Availability of Triamcinolone Hexacetonide in the United States Globe NewsWire - Wed Jun 9, 2021

TORONTO and CHICAGO and MONTREAL, June 09, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or  “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731)   announced today...

MDP.VN : 7.750 (-4.91%)
MEDXF : 1.3500 (+3.85%)

Barchart Exclusives

Stock Index Futures Climb on Upbeat Big Tech Earnings, U.S. Inflation Data Looms Barchart - 1 hour ago
June S&P 500 E-Mini futures (ESM24) are up +0.63%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.86% this morning as upbeat quarterly results from tech titans Alphabet and Microsoft boosted sentiment, while investors geared up for the release of the Fed’s preferred inflation gauge. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot